Patent · US Active

Anti-CD324 monoclonal antibodies and uses thereof

US9534058B2 · kind B2 · utility

6Cited by
17References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 8, 2013
Grant dateJan 3, 2017
Priority date—
Expiry dateFeb 8, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.